Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


BLOG

Kellogg's opens Broadway cafe

US cereal giant Kellogg's revealed plans to open a cafe in New York City, located at a prime location on Broadway....

BLOG

The Brexiteers are here, here and here

Wow. Your correspondent is penning this blog following precious little sleep after the combination of a humid night in London and the emergence of the most significant event in UK history since 1945 m...

BLOG

Now four Unilever CEOs sound Brexit warning

The last three Unilever CEOs have joined present chief executive Paul Polman in writing to the company's staff to warn the group's UK operations would be "negatively impacted" by the country leaving t...

just-food homepage



Forgot your password?